Location Geneva, Geneve, Switzerland Regions Europe, Middle East, and Africa (EMEA)
LinkedIn View on LinkedIn X (Twitter) View on X
Thomas Gurry is a computational biologist and translational microbiome scientist by training. He obtained a BSc in Biochemistry from Imperial College London and an MPhil in Computational Biology from the University of Cambridge, after which he moved to MIT to do a PhD studying protein folding in the context of neurodegenerative diseases. After
completing his PhD in 2014, he conducted postdoctoral research at the MIT Microbiome Center on the fermentation of dietary fibre by the gut microbiome into Short Chain Fatty Acids (SCFAs) and their impact on human health and disease. Since then, he has co-founded Myota, a company working to translate the current understanding of the importance of SCFAs to the treatment and prevention of chronic disease and maintenance of overall health into convenient and cost-effective fibre-based solutions for the ordinary person. In addition to his entrepreneurial and research activities, Thomas has consulted for numerous start-ups on both strategic and technical levels.
